title: Tolerability of two different combinations of antiretroviral drugs including tenofovir used in occupational and nonoccupational postexposure prophylaxis for HIV.
authors.forename: Christine
authors.initials: C
authors.lastname: Burty
authors.forename: Thierry
authors.initials: T
authors.lastname: Prazuck
authors.forename: Francois
authors.initials: F
authors.lastname: Truchetet
authors.forename: Bernard
authors.initials: B
authors.lastname: Christian
authors.forename: Christian
authors.initials: C
authors.lastname: Penalba
authors.forename: Dominique
authors.initials: D
authors.lastname: Salmon-Ceron
authors.forename: Yazdan
authors.initials: Y
authors.lastname: Yazdanpanah
authors.forename: Thierry
authors.initials: T
authors.lastname: May
authors.forename: Christian
authors.initials: C
authors.lastname: Rabaud
mesh_terms: D000225:Adenine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage* / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination / Q000009:adverse effects; D005260:Female; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D017758:Infectious Disease Transmission, Patient-to-Professional / Q000517:prevention & control; D008297:Male; D016273:Occupational Exposure / Q000517:prevention & control*; D009786:Occupational Health Services; D063065:Organophosphonates / Q000008:administration & dosage* / Q000009:adverse effects* / Q000627:therapeutic use; D010349:Patient Compliance; D000068698:Tenofovir
chemical_list: D019380:Anti-HIV Agents; D063065:Organophosphonates; D000068698:Tenofovir; D000225:Adenine